Cargando…
miR-146a deficiency does not aggravate muscular dystrophy in mdx mice
Duchenne muscular dystrophy (DMD) is a genetic disease evoked by a mutation in the dystrophin gene. It is associated with progressive muscle degeneration and increased inflammation. Up to this date, mainly anti-inflammatory treatment is available for patients suffering from DMD. miR-146a is known to...
Autores principales: | Bronisz-Budzyńska, Iwona, Chwalenia, Katarzyna, Mucha, Olga, Podkalicka, Paulina, Karolina-Bukowska-Strakova, Józkowicz, Alicja, Łoboda, Agnieszka, Kozakowska, Magdalena, Dulak, Józef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693262/ https://www.ncbi.nlm.nih.gov/pubmed/31412923 http://dx.doi.org/10.1186/s13395-019-0207-0 |
Ejemplares similares
-
Lack of miR-378 attenuates muscular dystrophy in mdx mice
por: Podkalicka, Paulina, et al.
Publicado: (2020) -
Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2021) -
miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2022) -
Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019) -
The role of Nrf2 in acute and chronic muscle injury
por: Bronisz-Budzyńska, Iwona, et al.
Publicado: (2020)